FDA Policy for REMS Reqmts during COVID-19

Health Care, Pharma Industry, Strategic Planning

FDA is issuing this guidance to communicate its temporary policy for certain risk evaluation and mitigation strategies (REMS) requirements for the duration of the coronavirus pandemic public health emergency.

Read the Policy now

Related Education Resources.

All Resources

GCSG App User Guide

Topic: Conference

Conference Training

Free

Forecasting

Topics: EAP, Forecasting / Planning

Video

Members

Commercialization of Personalized Medicines

Topic: Pharma Industry

Report

Members

Become a member

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.

Join Renew